'For a vaccine to work, our immune system needs to be stimulated to produce a neutralizing antibody, as opposed to a non-neutralizing antibody.' https://wp.me/pccWMe-25 

'In some viruses, if a person harbors a non-neutralizing antibody to the virus, a subsequent infection by the virus can cause that person to elicit a more severe reaction to the virus due to the presence of the non-neutralizing antibody.'

'This is called Antibody Dependent Enhancement (ADE), and is a common problem with Dengue Virus, Ebola Virus, HIV, RSV, and the family of coronaviruses.  In fact, this problem of ADE is a major reason why many previous vaccine trials for other coronaviruses failed.'

'Major safety concerns were observed in animal models. If ADE occurs in an individual, their response to the virus can be worse than their response if they had never developed an antibody in the first place.'

'The non-neutralizing antibody enables the virus to hitch a ride to infect immune cells. This can cause a hyperinflammatory response, a cytokine storm, & a general dysregulation of the immune system that allows the virus to cause more damage to our lungs & other organs.'

'There are many studies (in the reference section below) that demonstrate that ADE is a persistent problem with coronaviruses in general, and in particular, with SARS-related viruses.'

'A coronavirus vaccine may not be dangerous initially. If the initial testing looks positive, mass vaccination efforts would presumably be administered to a large portion of the population. In the first year or two it may appear that there is no real safety issue & over time'

'During this interim period, the virus is busy mutating. When these previously vaccinated people are infected with this different strain of SARS-CoV-2, they could experience a much more severe reaction to the virus.'

'Ironically, this vaccine made the virus more pathogenic rather than less pathogenic. This is not something that vaccine producers would be able predict or test for with any level of real confidence at the outset, & it would only become evident at a later time

'a clinical trial for a vaccine does NOT include administering the vaccine to a person, & then exposing this person to the virus post-vaccination to monitor their reaction. In clinical trials, humans are only given the vaccine, they are not “challenged” with the virus afterward'

'In a real infection, our immune system is exposed to every nook and cranny of the entire virus, and as such, our immune system develops a panacea of antibodies that recognize different portions of the virus and, therefore, coat more of the virus and neutralize it..>

>..In addition, our immune system develops T-Cell responses to hundreds of different peptide epitopes across the virus; whereas in the vaccine the plethora of these T-Cell responses are absent.'

'Based on these differences and the skewed immunological response which is inherent with vaccines, I believe that the risk of ADE is an order of magnitude greater in a vaccine-primed immune system rather than a virus-primed immune system.'

'Right now, the fatality rate of the virus is estimated to be approximately 0.26% . I believe this risk of developing ADE in a vaccinated individual will be much greater than 0.26%, and, therefore, the vaccine stands to make the problem worse, not better.'

References

More references

And more references